Track Lilly(Eli)'s total assets ($120B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total assets for LLY is $120B as of March 2026. That compares with $89B in the prior-year period — up 30.4% year over year. Investors often review this figure alongside Lilly(Eli)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, LLY's total assets moved from $89B to $120B — a 30.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lilly(Eli)'s operating scale or balance-sheet position.
A total assets figure of $120B for LLY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting LLY's total assets ($120B), review year-over-year change from $89B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Lilly(Eli)'s total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.